Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Cipla
Moodys
Chinese Patent Office
Teva
Daiichi Sankyo
Healthtrust
Chubb

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,988,731

« Back to Dashboard

Summary for Patent: 4,988,731
Title: Sodium hydrogen divalproate oligomer
Abstract:This invention concerns certain diethyl- or dipropylacetic acid salts of sodium valproate which have physiological properties similar to those of valproic acid or sodium valproate but show highly superior stability characteristics.
Inventor(s): Meade; Edwin M. (Duncan, CA)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:07/117,945
Patent Claim Types:
see list of patent claims
Compound; Use; Dosage form;

Drugs Protected by US Patent 4,988,731

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,988,731

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0034172 ➤ Try a Free Trial
Germany 3063328 ➤ Try a Free Trial
Canada 1136151 ➤ Try a Free Trial
Belgium 884848 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Cerilliant
Harvard Business School
Healthtrust
Mallinckrodt
Deloitte
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.